Static Chart Compass Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-30 EDT			5-day change	1st Jan Change
0.7865 ^USD	+4.01%		+3.35%	-85.35%

10-24	Compass Therapeutics Announces Publication Of Phase 2/3 COMPANION-002 Results For Tovecimig In The Journal Of Clinical Oncology And Oral Presentation At ESMO 2026	CI
09-23	Compass Therapeutics Shares Drop After Downgrade From Wedbush	MT

Duration

Period